In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
October 10th, 2004 | 25 | Yes |
Popular Name: Naltrexone Hydrochloride Naltrexone Hydrochloride
Find On: PubMed — Wikipedia — Google
CAS Numbers: 16590-41-3 , 16676-29-2 , 16676-29-2, 16590-41-3 [ , 16676-29-2, 16590-41-3 [naltrexone] , [16590-41-3]
16590-41-3; C07253; Naltrexone
16590-41-3; D05113; Naltrexone (USAN/INN); Vivitrol (TN)
16676-29-2; D02095; Naltrexone hydrochloride (USP); ReVia (TN)
16676-29-2; Naltrexone hydrochloride; Prestwick_348
17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxmorphinan-6-one, (5.alpha.)-
17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one
17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one
3,14-dihydroxy-17-(cyclopropylmethyl)-4,5alpha-epoxymorphinan-6-one
CPD000058767; NALTREXONE HYDROCHLORIDE; SAM002589986
EN-1639A; EN-1639A [As Hydrochloride]
Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-alpha-epoxy-3,14-dihydroxy-
Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-, (5alpha)-
N-Cyclopropylmethyl-14-hydroxydihydromorphinone
N-Cyclopropylmethylnoroxymorphone
Naltrexone hydrochloride dihydrate
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 1.35 | 4.74 | -58.23 | 3 | 5 | 1 | 71 | 342.415 | 2 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 3.07e+00 g/l | DrugBank-approved |
Indications | antidependency | KeyOrganics Bioactives |
PUBCHEM_PATENT_ID | EP0005636A1; EP0107855A1; EP0144341A1; EP0170090A1; EP0250796A2; EP0263968A2; EP0567205A1; EP0850050B1; EP0911334A1; EP0954314A1; US4089855; US4217353; US4477457; US4478840; US4496570; US4668685; US4673679; US4722928; US4990617; US5071985; US5760044; US59 | IBM Patent Data |
Therapy | morphine antagonist | SMDC Pharmakon |
PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : LightBiologicals; NCC_SUPPLIER_STRUCTURE_ID : N-3631; NCC_SUPPLIER_SAMPLE_COMMENTS : WHITE TO OFF-WHITE POWDER; 1 hydrogen chloride | NIH Clinical Collection via PubChem |
Target | Opioid Receptor | Selleck Chemicals |
PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: LightBiologicals; SUPPLIER_STRUCTURE_ID: N-3631; SALT: 1 hydrogen chloride; SUPPLIER_COMMENTS: WHITE TO OFF-WHITE POWDER | NIH Clinical Collection via PubChem |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
OPRD-1-E | Delta Opioid Receptor (cluster #1 Of 3), Eukaryotic | Eukaryotes | 95 | 0.39 | Binding ≤ 10μM |
OPRK-1-E | Kappa Opioid Receptor (cluster #1 Of 6), Eukaryotic | Eukaryotes | 10 | 0.45 | Binding ≤ 10μM |
OPRM-1-E | Mu-type Opioid Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 6 | 0.46 | Binding ≤ 10μM |
SGMR1-1-E | Sigma Opioid Receptor (cluster #1 Of 6), Eukaryotic | Eukaryotes | 22 | 0.43 | Binding ≤ 10μM |
OPRD-1-E | Delta Opioid Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5 | 0.46 | Functional ≤ 10μM |
OPRK-1-E | Kappa Opioid Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2 | 0.49 | Functional ≤ 10μM |
OPRM-1-E | Mu Opioid Receptor (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1 | 0.50 | Functional ≤ 10μM |
Z50512-1-O | Cavia Porcellus (cluster #1 Of 7), Other | Other | 50 | 0.41 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
OPRD_RAT | P33533 | Delta Opioid Receptor, Rat | 0.5 | 0.52 | Binding ≤ 1μM |
OPRD_MOUSE | P32300 | Delta Opioid Receptor, Mouse | 12.27 | 0.44 | Binding ≤ 1μM |
OPRD_HUMAN | P41143 | Delta Opioid Receptor, Human | 0.1 | 0.56 | Binding ≤ 1μM |
OPRK_RAT | P34975 | Kappa Opioid Receptor, Rat | 0.5 | 0.52 | Binding ≤ 1μM |
OPRK_HUMAN | P41145 | Kappa Opioid Receptor, Human | 0.1 | 0.56 | Binding ≤ 1μM |
OPRK_CAVPO | P41144 | Kappa Opioid Receptor, Guinea Pig | 0.373 | 0.53 | Binding ≤ 1μM |
OPRM_RAT | P33535 | Mu Opioid Receptor, Rat | 0.5 | 0.52 | Binding ≤ 1μM |
OPRM_CAVPO | P97266 | Mu Opioid Receptor, Guinea Pig | 0.325 | 0.53 | Binding ≤ 1μM |
OPRM_MOUSE | P42866 | Mu Opioid Receptor, Mouse | 0.265 | 0.54 | Binding ≤ 1μM |
OPRM_HUMAN | P35372 | Mu Opioid Receptor, Human | 0.1 | 0.56 | Binding ≤ 1μM |
SGMR1_RAT | Q9R0C9 | Sigma Opioid Receptor, Rat | 0.55 | 0.52 | Binding ≤ 1μM |
SGMR1_HUMAN | Q99720 | Sigma Opioid Receptor, Human | 5.7 | 0.46 | Binding ≤ 1μM |
OPRD_RAT | P33533 | Delta Opioid Receptor, Rat | 0.5 | 0.52 | Binding ≤ 10μM |
OPRD_MOUSE | P32300 | Delta Opioid Receptor, Mouse | 12.27 | 0.44 | Binding ≤ 10μM |
OPRD_HUMAN | P41143 | Delta Opioid Receptor, Human | 0.1 | 0.56 | Binding ≤ 10μM |
OPRK_RAT | P34975 | Kappa Opioid Receptor, Rat | 0.5 | 0.52 | Binding ≤ 10μM |
OPRK_HUMAN | P41145 | Kappa Opioid Receptor, Human | 0.1 | 0.56 | Binding ≤ 10μM |
OPRK_CAVPO | P41144 | Kappa Opioid Receptor, Guinea Pig | 0.373 | 0.53 | Binding ≤ 10μM |
OPRM_HUMAN | P35372 | Mu Opioid Receptor, Human | 0.1 | 0.56 | Binding ≤ 10μM |
OPRM_RAT | P33535 | Mu Opioid Receptor, Rat | 0.5 | 0.52 | Binding ≤ 10μM |
OPRM_CAVPO | P97266 | Mu Opioid Receptor, Guinea Pig | 0.325 | 0.53 | Binding ≤ 10μM |
OPRM_MOUSE | P42866 | Mu Opioid Receptor, Mouse | 0.265 | 0.54 | Binding ≤ 10μM |
SGMR1_RAT | Q9R0C9 | Sigma Opioid Receptor, Rat | 0.55 | 0.52 | Binding ≤ 10μM |
SGMR1_HUMAN | Q99720 | Sigma Opioid Receptor, Human | 5.7 | 0.46 | Binding ≤ 10μM |
Z50512 | Z50512 | Cavia Porcellus | 50 | 0.41 | Functional ≤ 10μM |
OPRD_HUMAN | P41143 | Delta Opioid Receptor, Human | 5.44 | 0.46 | Functional ≤ 10μM |
OPRK_HUMAN | P41145 | Kappa Opioid Receptor, Human | 1.86 | 0.49 | Functional ≤ 10μM |
OPRM_HUMAN | P35372 | Mu Opioid Receptor, Human | 0.59 | 0.52 | Functional ≤ 10μM |
Description | Species |
---|---|
G alpha (i) signalling events | |
G-protein activation | |
Opioid Signalling | |
Peptide ligand-binding receptors |